AntibioticMech

Browse · ANTIBACTERIAL

ofloxacin

antibioticmech:aro-2eea3233f3 ·ANTIBACTERIAL ·MINTED SEEDED

Ofloxacin is a 6-fluoro, 7-piperazinyl quinolone with a methyl-substituted oxazine ring. It has a broad spectrum of activity including many enterobacteria and mycoplasma but most anaerobes are resistant. — PMID:18159374

Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.

Classification

fluoroquinolone antibioticARO:0000001

Strictly broader compounds or drug classes this molecule belongs to.

Chemical structure

Computed structure properties
Molecular formulaC18H20FN3O4
Charge0
Average mass361.4 Da
Monoisotopic mass361.14378429 Da
SourcePubChem · retrieved 2026-08-29
InChIKeyGSDSWSVVBLHKDQ-UHFFFAOYSA-N

SMILES

CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O

InChI

InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)

Also called

Cross-references

Identifiers for this same structure in other resources. An accession that lands on two different structures in this corpus is withheld from both rather than shown here, since it names at most one of them.

Activity roles

Every antimicrobial role a source asserts for this compound — the unreduced evidence behind its antimicrobial_class.

Source concepts

Every upstream concept that resolved to this record. The merge is the product: this is what shows ChEBI and CARD are describing the same structure.

Upstream concepts merged into this record
SourceNative IDLabelMinted CURIEVersion
ARO ARO:3000663 ofloxacin antibioticmech:aro-2eea3233f3 2026-08-30

Molecular targets

The molecular entity or process this compound acts on. Each target carries evidence — this is a mechanistic claim, not a classification.

fluoroquinolone sensitive gyrA PROTEIN DIRECT_BINDING_TARGET

ARO:3000733

CARD/ARO database assertion; target organism, strain, and assay are not specified. ARO explicitly describes ligand binding to gyrase subunit A. Evidence status: PRIMARY_EVIDENCE_NEEDED. Source: CARD_ARO 2026-08-30 (retrieved 2026-08-30).

Fluoroquinolone sensitive parC PROTEIN DIRECT_BINDING_TARGET

ARO:3000735

CARD/ARO database assertion; target organism, strain, and assay are not specified. ParC is asserted as the fluoroquinolone-sensitive subunit. Evidence status: PRIMARY_EVIDENCE_NEEDED. Source: CARD_ARO 2026-08-30 (retrieved 2026-08-30).

Mechanism summary

Mode of action
NUCLEIC_ACID_SYNTHESIS_INHIBITION microbial target — Assigned from ChEBI role CHEBI:50750 (EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor), CHEBI:53559 (topoisomerase IV inhibitor), CHEBI:59517 (DNA synthesis inhibitor). ChEBI asserts the role on the compound. The role names a target specific to the microbe or virus — see mode_of_action_target_scope. Not a curator's mechanistic review.
Clinical status
APPROVED

Activity spectrum

Measured or curated activity against specific taxa. A number without a method is not an observation — every row here carries an assay.

76 observations · Browse all observations · Complete record (JSON.gz)

Activity observations
OrganismActivityMICDisk diffusionAssayStrainSample/genomeEvidence
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; CLIRES2020; liquid media; MGIT; MGIT960 — 1559 source isolates
1559 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; CLIRES2020; liquid media; MGIT; MGIT960 — 2902 source isolates
2902 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; CLIRES2020; not specified — 3 source isolates
3 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; CLIRES2020; not specified — 14 source isolates
14 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex INTERMEDIATE — — CRyPTIC DST; CLIRES2020; solid media — 1 source isolates
1 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; CLIRES2020; solid media — 147 source isolates
147 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; CLIRES2020; solid media — 816 source isolates
816 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; CLIRES2023; liquid media; MGIT; MGIT960 — 321 source isolates
321 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; CLIRES2023; liquid media; MGIT; MGIT960 — 579 source isolates
579 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; CLIRES2023; not specified — 1 source isolates
1 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; CLIRES2023; solid media — 8 source isolates
8 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; CLIRES2023; solid media — 1 source isolates
1 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; KMMYKROBE2025; not specified — 24 source isolates
24 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; KMMYKROBE2025; not specified — 122 source isolates
122 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; KMVALIDATION2025; not specified — 396 source isolates
396 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; KMVALIDATION2025; not specified — 3315 source isolates
3315 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; LID2015; liquid media; MGIT; MGIT960; critical concentration WHO mg/L — 27 source isolates
27 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; LID2015; liquid media; MGIT; MGIT960; critical concentration WHO mg/L — 775 source isolates
775 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; MUMBAI2018; liquid media; MGIT; MGIT960 — 326 source isolates
326 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; MUMBAI2018; liquid media; MGIT; MGIT960 — 503 source isolates
503 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; NEJM2018; liquid media; MGIT; MGIT960 — 182 source isolates
182 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; NEJM2018; liquid media; MGIT; MGIT960 — 1115 source isolates
1115 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; NEJM2018; solid media; LJ; resistance ratio — 190 source isolates
190 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; NEJM2018; solid media; LJ; resistance ratio — 584 source isolates
584 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; NEJM2018; solid media; middlebrook; proportion method — 53 source isolates
53 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; NEJM2018; solid media; middlebrook; proportion method — 102 source isolates
102 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; PHE2019; liquid media; MGIT; MGIT960; critical concentration WHO mg/L — 36 source isolates
36 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; PHE2019; liquid media; MGIT; MGIT960; critical concentration WHO mg/L — 158 source isolates
158 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; SEQTREAT2020; liquid media; MGIT; BACTEC460; critical concentration 2.0 mg/L — 4 source isolates
4 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; SEQTREAT2020; liquid media; MGIT; BACTEC460; critical concentration 2.0 mg/L — 13 source isolates
13 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; SEQTREAT2020; liquid media; MGIT; MGIT960; critical concentration 2.0 mg/L — 27 source isolates
27 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; SEQTREAT2020; liquid media; MGIT; MGIT960; critical concentration 2.0 mg/L — 163 source isolates
163 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — — — CRyPTIC DST; SEQTREAT2020; liquid media; MGIT; MGIT960; critical concentration 2.0 mg/L — 412 source isolates
412 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; SEQTREAT2020; liquid media; MGIT; MGIT960; critical concentration WHO mg/L — 31 source isolates
31 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; SEQTREAT2020; liquid media; MGIT; MGIT960; critical concentration WHO mg/L — 238 source isolates
238 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — — — CRyPTIC DST; SEQTREAT2020; liquid media; MGIT; MGIT960; critical concentration WHO mg/L — 487 source isolates
487 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — 0.5 mg/L — CRyPTIC DST; SEQTREAT2020; liquid media; microdilution plate; MYCOTB — 20 source isolates
20 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — 1.0 mg/L — CRyPTIC DST; SEQTREAT2020; liquid media; microdilution plate; MYCOTB — 48 source isolates
48 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — 16.0 mg/L — CRyPTIC DST; SEQTREAT2020; liquid media; microdilution plate; MYCOTB — 10 source isolates
10 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — 2.0 mg/L — CRyPTIC DST; SEQTREAT2020; liquid media; microdilution plate; MYCOTB — 11 source isolates
11 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — 32.0 mg/L — CRyPTIC DST; SEQTREAT2020; liquid media; microdilution plate; MYCOTB — 3 source isolates
3 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — 4.0 mg/L — CRyPTIC DST; SEQTREAT2020; liquid media; microdilution plate; MYCOTB — 7 source isolates
7 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — 8.0 mg/L — CRyPTIC DST; SEQTREAT2020; liquid media; microdilution plate; MYCOTB — 17 source isolates
17 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — <=0.25 mg/L — CRyPTIC DST; SEQTREAT2020; liquid media; microdilution plate; MYCOTB — 4 source isolates
4 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — 16.0 mg/L — CRyPTIC DST; SEQTREAT2020; liquid media; microdilution plate; colourmetric — 1 source isolates
1 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — 2.0 mg/L — CRyPTIC DST; SEQTREAT2020; liquid media; microdilution plate; colourmetric — 2 source isolates
2 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — 4.0 mg/L — CRyPTIC DST; SEQTREAT2020; liquid media; microdilution plate; colourmetric — 2 source isolates
2 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — 8.0 mg/L — CRyPTIC DST; SEQTREAT2020; liquid media; microdilution plate; colourmetric — 10 source isolates
10 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — >16.0 mg/L — CRyPTIC DST; SEQTREAT2020; liquid media; microdilution plate; colourmetric — 1 source isolates
1 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; SEQTREAT2020; not specified — 2 source isolates
2 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — — — CRyPTIC DST; SEQTREAT2020; not specified — 442 source isolates
442 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; SEQTREAT2020; solid media; LJ; critical concentration 2.0 mg/L — 3 source isolates
3 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; SEQTREAT2020; solid media; LJ; critical concentration 2.0 mg/L — 168 source isolates
168 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — — — CRyPTIC DST; SEQTREAT2020; solid media; LJ; critical concentration 2.0 mg/L — 16 source isolates
16 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; SEQTREAT2020; solid media; LJ; critical concentration WHO mg/L — 206 source isolates
206 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; SEQTREAT2020; solid media; LJ; critical concentration WHO mg/L — 1223 source isolates
1223 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — — — CRyPTIC DST; SEQTREAT2020; solid media; LJ; critical concentration WHO mg/L — 229 source isolates
229 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; SEQTREAT2020; solid media; middlebrook; 7H10; critical concentration 2 mg/L — 336 source isolates
336 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; SEQTREAT2020; solid media; middlebrook; 7H10; critical concentration 2.0 mg/L — 87 source isolates
87 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; SEQTREAT2020; solid media; middlebrook; 7H10; critical concentration 2.0 mg/L — 93 source isolates
93 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; SEQTREAT2020; solid media; middlebrook; critical concentration 1.0 mg/L — 16 source isolates
16 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; SEQTREAT2020; solid media; middlebrook; critical concentration 1.0 mg/L — 69 source isolates
69 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — — — CRyPTIC DST; SEQTREAT2020; solid media; middlebrook; critical concentration 1.0 mg/L — 9 source isolates
9 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; SEQTREAT2020; solid media; middlebrook; critical concentration 2 mg/L — 41 source isolates
41 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; SEQTREAT2020; solid media; middlebrook; critical concentration 2 mg/L — 381 source isolates
381 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — — — CRyPTIC DST; SEQTREAT2020; solid media; middlebrook; critical concentration 2 mg/L — 22 source isolates
22 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; SEQTREAT2020; solid media; middlebrook; critical concentration 2.0 mg/L — 14 source isolates
14 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; SEQTREAT2020; solid media; middlebrook; critical concentration 2.0 mg/L — 70 source isolates
70 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — — — CRyPTIC DST; SEQTREAT2020; solid media; middlebrook; critical concentration 2.0 mg/L — 9 source isolates
9 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; SEQTREAT2020; solid media; middlebrook; critical concentration 4.0 mg/L — 10 source isolates
10 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; SEQTREAT2020; solid media; middlebrook; critical concentration 4.0 mg/L — 74 source isolates
74 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex — — — CRyPTIC DST; SEQTREAT2020; solid media; middlebrook; critical concentration 4.0 mg/L — 9 source isolates
9 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; WHO2019; liquid media; MGIT; MGIT960; critical concentration 2.0 mg/L — 95 source isolates
95 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; WHO2019; liquid media; MGIT; MGIT960; critical concentration 2.0 mg/L — 985 source isolates
985 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex RESISTANT — — CRyPTIC DST; WHO2019; solid media; LJ; critical concentration 4.0 mg/L — 70 source isolates
70 measurements
Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex SUSCEPTIBLE — — CRyPTIC DST; WHO2019; solid media; LJ; critical concentration 4.0 mg/L — 1068 source isolates
1068 measurements
Evidence Page data (JSON.gz)

Resistance mechanisms

35 source-backed resistance determinants or associations, with ARO grounding where reported. Grouped by reported mechanism type.

ANTIBIOTIC_TARGET_ALTERATION 27
ANTIBIOTIC_TARGET_ALTERATION
DeterminantARO IDOrganismGene familiesEvidence
Acinetobacter baumannii gyrA conferring resistance to fluoroquinolones ARO:3003817 not organism-specific —
  • ARO:3003817 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Acinetobacter baumannii parC conferring resistance to fluoroquinolones ARO:3003818 not organism-specific —
  • ARO:3003818 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Bartonella bacilliformis gyrA conferring resistance to fluoroquinolones ARO:3003297 not organism-specific —
  • ARO:3003297 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Clostridioides difficile gyrA conferring resistance to fluoroquinolones ARO:3003995 not organism-specific —
  • ARO:3003995 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Escherichia coli gyrA conferring resistance to fluoroquinolones ARO:3003294 not organism-specific —
  • ARO:3003294 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Escherichia coli parC conferring resistance to fluoroquinolones ARO:3003308 not organism-specific —
  • ARO:3003308 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Escherichia coli parE conferring resistance to fluoroquinolones ARO:3003316 not organism-specific —
  • ARO:3003316 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Morganella morganii gyrB conferring resistance to fluoroquinolones ARO:3003306 not organism-specific —
  • ARO:3003306 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Mycobacterium leprae gyrA conferring resistance to fluoroquinolones ARO:3003298 not organism-specific —
  • ARO:3003298 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Mycobacterium leprae gyrB conferring resistance to fluoroquinolones ARO:3003304 not organism-specific —
  • ARO:3003304 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Mycobacterium tuberculosis eccB5 conferring resistance to fluoroquinolones ARO:3004918 not organism-specific —
  • ARO:3004918 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Mycobacterium tuberculosis eccC5 conferring resistance to fluoroquinolones ARO:3004919 not organism-specific —
  • ARO:3004919 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones ARO:3003295 not organism-specific —
  • ARO:3003295 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Mycobacterium tuberculosis gyrA mutations conferring resistance to ofloxacin ARO:3007807 not organism-specific —
  • ARO:3007807 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Mycobacterium tuberculosis gyrB mutations conferring resistance to ofloxacin ARO:3007808 not organism-specific —
  • ARO:3007808 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Mycobacterium tuberculosis gyrB with mutation conferring resistance to fluoroquinolones ARO:3003459 not organism-specific —
  • ARO:3003459 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Mycoplasma hominis parC conferring resistance to fluoroquinolones ARO:3003310 not organism-specific —
  • ARO:3003310 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Pseudomonas aeruginosa gyrA conferring resistance to fluoroquinolones ARO:3003684 not organism-specific —
  • ARO:3003684 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Pseudomonas aeruginosa parC conferring resistance to fluoroquinolones ARO:3003702 not organism-specific —
  • ARO:3003702 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Salmonella serovars gyrB conferring resistance to fluoroquinolones ARO:3003307 not organism-specific —
  • ARO:3003307 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Salmonella serovars parE conferring resistance to fluoroquinolones
Evidence-scope review 2026-10-16-salmonella-pare-evidence-scope: The cited Enteritidis study found no independent parE effect in its tested background; an indirect contribution remained unresolved. This is not a universal inactivity claim or evidence for every serovar and inherited compound. Retain CARD's assertion as database evidence, without assigning an experimental protein, allele, taxon or susceptibility observation. Qualification references, not an upgrade of the CARD assertion: DOI:10.1128/aac.01005-08 (Results: Contribution of target gene mutations to quinolone resistance; Table 1: quinolone headers and relevant parE comparison; Table 3: compound headers and absence of a parE-specific comparison; Discussion: paragraph beginning Although complementation; publisher HTML text and selected table text; no visual table, figure or supplement verification). Reviewed 2026-10-16 by Codex; curation/card_evidence_reviews.json SHA-256 584f3e32ce0122eb2315fe09bbe22e058539bef184ad2d75756a6f3016bf2687.
ARO:3003317 not organism-specific —
  • ARO:3003317 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Staphylococcus aureus gyrA conferring resistance to fluoroquinolones ARO:3003296 not organism-specific —
  • ARO:3003296 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Staphylococcus aureus parC conferring resistance to fluoroquinolones ARO:3003312 not organism-specific —
  • ARO:3003312 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Staphylococcus aureus parE conferring resistance to fluoroquinolones ARO:3003315 not organism-specific —
  • ARO:3003315 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Streptococcus pneumoniae parC conferring resistance to fluoroquinolones ARO:3003311 not organism-specific —
  • ARO:3003311 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Ureaplasma urealyticum gyrB conferring resistance to fluoroquinolones ARO:3003305 not organism-specific —
  • ARO:3003305 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Ureaplasma urealyticum parC conferring resistance to fluoroquinolones ARO:3003309 not organism-specific —
  • ARO:3003309 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
ANTIBIOTIC_EFFLUX 8
ANTIBIOTIC_EFFLUX
DeterminantARO IDOrganismGene familiesEvidence
MexCD-OprJ ARO:3000797 not organism-specific —
  • ARO:3000797 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
MexXY-OprA ARO:3003038 not organism-specific —
  • ARO:3003038 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
MexXY-OprM ARO:3003032 not organism-specific —
  • ARO:3003032 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
QepA3 ARO:3004378 not organism-specific —
  • ARO:3004378 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Rv1877 ARO:3007662 not organism-specific —
  • ARO:3007662 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
Staphylococcus aureus norA ARO:3004667 not organism-specific —
  • ARO:3004667 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
abeM ARO:3000753 not organism-specific —
  • ARO:3000753 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)
putative nickel/cobalt transporter ARO:3007659 not organism-specific —
  • ARO:3007659 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000663 (ofloxacin); database assertion, not a primary citation.)

Causal graphs

Evidence-backed mechanism graphs: how the compound reaches its target, what the target does, and how the effect propagates to growth inhibition or death.

Ofloxacin inhibits bacterial DNA gyrase supercoiling MECHANISTIC

Ofloxacin inhibits the DNA gyrase-catalyzed supercoiling reaction, disrupting bacterial chromosome topology control.

Nodes — ofloxacin_dna_gyrase_supercoiling_inhibition
NodeLabelTypeGrounding
ofloxacin ofloxacin COMPOUND antibioticmech:aro-2eea3233f3
dna_gyrase bacterial DNA gyrase
Examples: DNA gyrase subunit A (gyrA) UniProtKB:P0AES4, Escherichia coli (strain K12) NCBITaxon:83333 REVIEWED — Reference-strain bacterial DNA gyrase subunit A for the ARO:3000733 node grounding (E. coli K-12 reference context; PMID:3010848 assayed purified Micrococcus luteus DNA gyrase without a strain-specific reviewed Swiss-Prot entry).; DNA gyrase subunit B (gyrB) UniProtKB:P0AES6, Escherichia coli (strain K12) NCBITaxon:83333 REVIEWED — Reference-strain bacterial DNA gyrase subunit B for the ARO:3000733 node grounding (E. coli K-12 reference context; PMID:3010848 assayed purified Micrococcus luteus DNA gyrase).
GENE_OR_PROTEIN ARO:3000733
dna_supercoiling ATP-dependent DNA supercoiling BIOLOGICAL_PROCESS REVIEWED_LABEL_ONLY
dna_topology_control bacterial DNA topology control BIOLOGICAL_PROCESS REVIEWED_LABEL_ONLY
Edges — ofloxacin_dna_gyrase_supercoiling_inhibition
SubjectPredicateObjectEvidence
ofloxacin inhibits dna_supercoiling
  • DOI:10.1128/AAC.31.2.325 (Imamura and colleagues compared the ability of optically active ofloxacin forms to inhibit Escherichia coli DNA gyrase.)
  • PMID:3010848 (Zweerink and Edison included ofloxacin in comparative Micrococcus luteus DNA gyrase supercoiling assays.)
dna_gyrase enables dna_supercoiling
  • PMID:3010848 (The purified-enzyme assay measured quinolone inhibition of supercoiling by Micrococcus luteus DNA gyrase.)
dna_supercoiling supports dna_topology_control
  • PMID:3010848 (The in vitro comparison links quinolone-sensitive DNA gyrase activity to DNA supercoiling.)

Curation history

  1. SEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Seeded from data/raw/ inventories (ARO)

  2. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  3. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  4. RESEEDED_FROM_SOURCES 2026-08-31 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  5. RESEEDED_FROM_SOURCES 2026-08-31 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  6. RESEEDED_FROM_SOURCES 2026-08-31 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  7. CURATED_CAUSAL_GRAPH 2026-09-04 · codex · LLM-assisted

    Added primary-literature support for a causal graph of ofloxacin inhibition of bacterial DNA gyrase supercoiling.

  8. RESEEDED_FROM_SOURCES 2026-09-26 · seed_from_sources

    Re-seeded; changed: activity_spectrum (CRYPTIC 3.4.0). Upstream retrieval date 2026-08-30, unchanged.

  9. RESEEDED_FROM_SOURCES 2026-10-05 · seed_from_sources

    Re-seeded; changed: activity_membership_collections (CRYPTIC 3.4.0). Upstream retrieval date 2026-08-30, unchanged.

  10. RESEEDED_FROM_SOURCES 2026-10-16 · seed_from_sources

    Re-seeded; changed: resistance_mechanisms (CARD). Upstream retrieval date 2026-08-30, unchanged.

  11. CURATED_UNIPROT_PROTEIN_EXAMPLES 2026-10-18 · antigravity · LLM-assisted

    Added curated E. coli K-12 reference-strain DNA gyrase subunit A (P0AES4) and subunit B (P0AES6) UniProtKB protein examples on the ofloxacin_dna_gyrase_supercoiling_inhibition dna_gyrase causal graph node.

Provenance

Seeded by scripts/seed_from_sources.py from the committed inventories in data/raw/. View the record (YAML).

Explore across X-Mech: MediaIngredientMech (ofloxacin) · CultureMech · NaturalProductMech · PathwayMech · TraitMech